Johnson & Johnson MedTech India partners with Karkinos to upskill professionals in cancer care
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
To bring quality cancer treatment closer to patients, India’s leading MedTech brand is joining forces with the unique technology-led platform
C2i Genomics expands its global reach and brings the first whole-genome sequencing minimal residual disease test to India
The target demographic will be those between the ages of 30 and 65 years
This strategic collaboration will enable continued innovation in cancer care
Subscribe To Our Newsletter & Stay Updated